Flexible Capital for
Healthcare Companies and Investors
Revelation Partners provides flexible capital solutions to the healthcare ecosystem. We specialize in providing liquidity for illiquid, private holdings and growth capital to allow investors to maximize their return.
We invest broadly across all healthcare sub-sectors, including medical devices, diagnostics, biotech, healthcare technology, and healthcare services.
With decades of investing experience, deep sector expertise, an extensive industry network, and over
$900 million of committed capital, Revelation Partners is a trusted partner to healthcare companies, investors, founders, and funds.
Learn more here.
Active Portfolio Companies
Total Value of Exited Companies
Typical Transaction Size
Proven Track Record
Dren Bio Announces $65 Million Series B Financing to Advance its Lead Asset into the Clinic and to Accelerate Development of New Product Candidates from its Targeted Myeloid Engager and Phagocytosis Platform